Ivan Randelovic MSc. is Biologist Researcher and Project Manager in Kineto Lab Research and Development Ltd, working on drug discovery screening and preclinical investigation and development of targeting cancer therapeutics.
He graduated at Belgrade University, Belgrade, Serbia, on Faculty of Biology, on Department of Molecular Biology and Physiology, module of Experimental Biomedicine in 2014. In his Master thesis he investigated anticancer activity and mechanism of actions of neutral and cationic Iridium (III) complexes with various sets of ligands.
From 2012. to 2014. he was a researcher in Cancer group at the Department of Immunology, on Institute for Biological Research „Siniša Stanković” (IBISS), University of Belgrade, Serbia, where he did experimental part of Master thesis, testing and evaluating new therapeutics with anticancer properties in the treatment of cancer, determining their molecular mechanisms of action and signaling pathways that modulate the response to cancer therapy, under project: “Molecular mechanisms of physiological and pharmacological control of inflammation and cancer” (No. 173013) funded by the Ministry of Education, Science and Technological Development of the Republic of Serbia.
From 2015. as Marie Skłodowska-Curie PhD fellow he works on National Institute of Oncology, Budapest, Hungary, at the Department of Experimental Pharmacology, under supervision of Dr. Jozsef Tóvári, investigating the effect of peptide-drug bio-conjugates on tumor growth and metastasis in vitro and in vivo, in frame of Marie Skodowska-Curie Innovative Training Network (ITN-ETN) “Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy – MAGICBULLET” project; Grant no: 642004.
In 2017. he was on secondment in Translational Cancer Biology lab on Biomedicum at Helsinki University, Helsinki, Finland, and in 2018. in Molecular Biology lab at Preclinical Research Department at the Research Center of Italfarmaco SpA, Milan, Italy.
From 2019. he is PhD candidate on Semmelweis University, Budapest, Hungary, at the Doctoral School of Pathological Sciences, on Experimental Oncology program.
He was Marie Skłodowska-Curie PhD study fellow in duration for 3 years, and holder of full tuition fee scholarship given by Ministry of Education, Science and Technological Development of the Republic of Serbia, and University of Belgrade for Bachelor and Master studies.